securities fraud

Hagens Berman alerts $CORT investors to April 21 lead plaintiff deadline in securities fraud class action alleging concealment of FDA concerns about relacorilant ahead of rejection.

Class action lawsuit alleges $PINS made false statements about advertising revenue declines and downplayed tariff impacts on business.

Schall Law Firm recruits investors for class action against Atara Biotherapeutics over alleged securities fraud involving tabelecleucel drug and ALLELE study claims, covering May 2024-January 2026 purchases.

Portnoy Law Firm files class action against $SNOW for allegedly concealing negative impact of product efficiency gains on revenues. Stock fell 18% post-disclosure.

Portnoy Law Firm launches class action against $SLNO for allegedly concealing safety issues with lead drug DCCR, citing 27% stock plunge following patient death disclosure.

Portnoy Law Firm investigates Beta Bionics for possible securities fraud after stock plummets 37% on disappointing Q4 2025 results showing user acquisition growth halved to 36%.

Portnoy Law Firm sues PayPal on behalf of investors, alleging management misled shareholders on revenue and growth targets before February earnings miss.

REGENXBIO faces class action lawsuit after FDA halted RGX-111 gene therapy trial due to CNS tumor, triggering 18% stock decline.

Schall Law Firm files class action against $GEMI for alleged securities fraud involving misrepresented crypto platform viability and overstated expansion prospects.

$GSIT shares fell 14.2% after legal investigation into allegedly misleading AI chip capability claims. Class action lawsuits being prepared to recover shareholder losses.

Aquestive Therapeutics faces class action lawsuit alleging FDA approval misrepresentations for Anaphylm. Stock dropped 37% January 9; lead plaintiff applications due May 4, 2026.

Corcept Therapeutics faces class action lawsuit for allegedly misleading investors about relacorilant's FDA prospects. Stock plummeted 50.4% after FDA rejection; investors from October 2024-December 2025 eligible to sue.

Rosen Law Firm investigates zSpace Inc. ($ZSPC) for allegedly misleading investor disclosures, preparing class action lawsuit seeking shareholder recovery.

Rosen Law Firm investigates SYLA Technologies ($SYT) for allegedly misleading shareholders. Class action lawsuits seek investor compensation for losses.

ODDITY Tech ($ODD) faces securities fraud lawsuit alleging failure to disclose algorithm changes by major ad partner that inflated customer acquisition costs and misled investors.

Pinterest faces class action lawsuit alleging misleading statements about advertising revenue amid tariff-related deterioration. Stock dropped $12.77 per share.

monday.com faces securities fraud lawsuit after abruptly withdrawing $1.8B revenue target five months post-projection, sparking 21% stock collapse.

Grocery Outlet ($GO) sued for securities fraud; CEO, CFO allegedly certified misleading statements about store expansion strategy. Stock fell 27.9% to $6.34.

Law firm Levi & Korsinsky filed class action suit against $CORT alleging fraud regarding relacorilant FDA approval prospects between October 2024 and December 2025.

Alight stock plummeted 90% amid securities fraud lawsuit alleging CEO and CFO misled investors on execution and costs before their departures.